#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary optic atrophy Infective uveitis Microvillous inclusion disease Immunodeficiency Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Propionic acidaemia Staphylococcal infection Kaposi's sarcoma Myxoid liposarcoma Hereditary motor and sensory neuropathy Arteriosclerosis Haematological malignancy Juvenile psoriatic arthritis Dent's disease Myotonic dystrophy More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa Hepatic angiosarcoma – Life with Disease Prolymphocytic leukaemia – Diagnostics Toxic epidermal necrolysis – Basic Information Factor VIII deficiency – Trials in Disease Osteosarcoma metastatic – Life with Disease Prader-Willi syndrome – Basic Information Soft tissue sarcoma – Trials in Disease Angiosarcoma non-metastatic – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydrocortisone Hemisuccinate Ly3819469 Sodium Air, Medicinal Pantothenate Sodium Darbepoetin Alfa Mycophenolate Mofetil Pegvaliase Tinengotinib Ecoo16 Gallium (68Ga) Gozetotide Canis Familiaris (553) Vidutolimod Atacicept Saline Cefepime Hydrochloride Glycine Atogepant VGA039 Levofloxacin Hemihydrate Piflufolastat (18F) More therapies…

    Learn about Your Condition

    Spina bifida Hereditary ataxia Oesophageal food impaction Oesophageal carcinoma Caesarean section Adenocarcinoma gastric Gastric cancer recurrent Mast cell activation syndrome Chronic disease Multifocal motor neuropathy Patent ductus arteriosus Adrenocortical carcinoma Giant cell arteritis B-cell lymphoma recurrent Arteriovenous graft thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Elexacaftor
    • Ivacaftor
    • Tezacaftor
    Austria Belgium Czechia France Germany Hungary +7

  • Study on Zinc Acexamate for Patients with Advanced Chronic Liver Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Liver disorder
    Investigated Drugs:
    • Zinc Acexamate
    Spain

  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Not recruiting

    1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Golexanolone
    Germany Greece Hungary Italy Spain

  • Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Czechia Germany Poland Portugal Spain

  • Study on Cetuximab and Irinotecan for Patients with Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Cetuximab
    • Irinotecan
    Spain

  • Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anti-Pdcd1 Igg4 Humanised Monoclonal Antibody
    • Sasanlimab
    • Sacituzumab Govitecan
    Spain

  • Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia Finland Hungary Poland +2

  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    • Risankizumab
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Not recruiting

    3 1
    Investigated Drugs:
    • Itepekimab
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 … 26 27 28 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!